"10.1371_journal.pone.0038312","plos one","2012-06-08T00:00:00Z","Alessandro Tozzi; Antonio de Iure; Valentina Marsili; Rosaria Romano; Michela Tantucci; Massimiliano Di Filippo; Cinzia Costa; Francesco Napolitano; Nicola Biagio Mercuri; Franco Borsini; Carmen Giampà; Francesca Romana Fusco; Barbara Picconi; Alessandro Usiello; Paolo Calabresi","Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy; Fondazione Santa Lucia - IRCCS, Rome, Italy; CEINGE - Biotecnologie Avanzate, Naples, Italy; Sigma - tau Industrie Riunite, Pomezia, Italy; Second University of Naples (SUN), Naples, Italy","Conceived and designed the experiments: AT AU PC. Performed the experiments: AT AD VM RR CG. Analyzed the data: AT AD VM RR CG CC FRF. Wrote the paper: AT MD NBM FB BP MT FN AU PC.","Dr. Calabresi serves as an editorial board member of Lancet Neurology, the Journal of Neuroscience, Movement Disorders and Synapse; receives research support from Bayer Schering, Biogen, Boehringer Ingelheim, Eisai, Novartis, Lundbeck, Sanofi-Aventis, Sigma-Tau, and UCB Pharma; and from Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS [European Community Grants SYNSCAFF and REPLACES], the Italian Minister of Health and AIFA (Agenzia Italiana del Farmaco). Dr. Franco Borsini is employed by Sigma-tau Industrie Riunite, Pomezia, Italy. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials. All other authors reported no biomedical financial interests or potential conflicts of interest.","2012","06","Alessandro Tozzi","AT",15,TRUE,3,5,7,9,TRUE,TRUE,FALSE,0,NA,FALSE
